UK study to analyze proteins in 600,000 blood samples, aiming to detect diseases decades early.

A massive UK Biobank study, backed by major pharmaceutical companies, aims to analyze up to 5,400 proteins in 600,000 blood samples from half a million volunteers. This project could revolutionize healthcare by identifying early signs of diseases like dementia and cancer up to a decade before diagnosis, potentially leading to faster and more accurate blood tests for conditions such as multiple sclerosis and Crohn's disease. The data, available from 2026, could also aid in developing new drugs and repurposing existing ones.

2 months ago
20 Articles

Further Reading